Betmiga 25 mg


Prolonged-release tablet
scheduling status
S3
registration number
47/16.5/0297
What Betmiga 25 mg contains
25 mg of mirabegron.
other ingredients
Macrogol 8,000 and 2,000,000 Hydroxypropylcellulose Butylhydroxytoluene Magnesium stearate Hypromellose 2910, 6 mPa.s Macrogol 8,000 Iron oxide yellow (E172) Iron oxide red (E172).
Therapeutic classification
G04BD.
© 2026 SAHPRA. ALL RIGHTS RESERVED